128 related articles for article (PubMed ID: 2205423)
1. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.
Graf MJ; Richards CJ; Brown V; Meissner L; Dunaif A
Clin Endocrinol (Oxf); 1990 Jul; 33(1):119-31. PubMed ID: 2205423
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
[TBL] [Abstract][Full Text] [Related]
3. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
4. Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.
Tiitinen A; Pekonen F; Stenman UH; Laatikainen T
Hum Reprod; 1990 Apr; 5(3):242-5. PubMed ID: 2191000
[TBL] [Abstract][Full Text] [Related]
5. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
Dunaif A; Segal KR; Futterweit W; Dobrjansky A
Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
[TBL] [Abstract][Full Text] [Related]
6. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
7. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
8. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
9. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.
Norman RJ; Hague WM; Masters SC; Wang XJ
Hum Reprod; 1995 Sep; 10(9):2258-61. PubMed ID: 8530647
[TBL] [Abstract][Full Text] [Related]
10. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
Dunaif A; Graf M
J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
[TBL] [Abstract][Full Text] [Related]
12. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.
Slowińska-Srzednicka J; Zgliczyński S; Wierzbicki M; Srzednicki M; Stopińska-Gluszak U; Zgliczyński W; Soszyński P; Chotkowska E; Bednarska M; Sadowski Z
J Endocrinol Invest; 1991; 14(7):569-75. PubMed ID: 1940062
[TBL] [Abstract][Full Text] [Related]
13. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
[TBL] [Abstract][Full Text] [Related]
15. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
Dunaif A; Segal KR; Shelley DR; Green G; Dobrjansky A; Licholai T
Diabetes; 1992 Oct; 41(10):1257-66. PubMed ID: 1397698
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.
Prelević GM; Wurzburger MI; Balint-Perić L; Ginsburg J
Horm Res; 1992; 37(4-5):125-31. PubMed ID: 1490653
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
Legro RS; Kunselman AR; Dunaif A
Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
